On 3/4/20, CorMedix Inc (NYSEAMERICAN: CRMD) stock enjoyed a major increase of 13.0%, closing at $6.00. Moreover, trading volume in this advance was above average at 133% of normal. Relative to the market the stock has been weak over the last nine months but has risen 6.6% during the last week.
Current PriceTarget Research Rating
CRMD’s future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to be an important Value Eraser.
CorMedix is currently unrated.
The stock is currently unrated.